Progyny Inc
Research Progyny Inc (PGNY) on Bullrun: valuation model: 7.8% overvalued, market cap USD 2.00B, P/E 28.0. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPGNY
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryHealthcare Plans
- CurrencyUSD
- Valuation signal7.8% overvalued
- Market capUSD 2.00B
- P/E28.0
- Financial periodQ2 2026
- RevenueUSD 350.51M
- Net incomeUSD 28.05M
- Free cash flowUSD 44.21M
- Gross margin25.5%
Valuation Snapshot
Bullrun's latest valuation model marks Progyny Inc as 7.8% overvalued; latest market cap is USD 2.00B; P/E is 28.0.
Peer valuation comparison
Latest P/E is 28.04x versus a Healthcare sector median of 24.46x (14.7% above).
Latest P/E is 28.04x versus a United States median of 24.87x (12.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.29B | USD 58.52M | USD 191.78M | 23.6% | 0.65 | USD 112.24M | USD 27.73M | USD 516.04M |
| FY2024 | USD 1.17B | USD 54.34M | USD 173.70M | 21.7% | 0.57 | USD 162.31M | USD 19.27M | USD 422.06M |
| FY2023 | USD 1.09B | USD 62.04M | USD 185.17M | 21.9% | 0.62 | USD 97.30M | USD 19.39M | USD 553.43M |
| FY2022 | USD 786.91M | USD 30.36M | USD 77.15M | 21.3% | 0.3 | USD 120.08M | USD 6.96M | USD 376.97M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 2.00B | 28.0 | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.21B | 39.5 | n/a | n/a |
| 2024 | 2024-12-31 | USD 1.47B | 30.3 | n/a | n/a |
| 2023 | 2023-12-29 | USD 3.56B | 71.5 | n/a | n/a |
| 2022 | 2022-12-30 | USD 2.89B | 74.2 | n/a | n/a |
| 2021 | 2021-12-31 | USD 4.59B | 76.3 | n/a | n/a |
About Progyny Inc
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Progyny Inc overvalued or undervalued?
Bullrun's valuation model currently marks Progyny Inc as 7.8% overvalued.
What is Progyny Inc's market cap?
Progyny Inc's market capitalization is USD 2.00B.
What is Progyny Inc's P/E ratio?
Progyny Inc's price-to-earnings (P/E) ratio is 28.0.
What does Progyny Inc do?
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists.